Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report

BACKGROUND: Oxaliplatin is an anticancer therapy for pancreatic, gastric, and colorectal cancers. It is also used in patients with carcinomas of unknown primary sites. Oxaliplatin is associated with less frequent renal dysfunction than other conventional platinum-based drugs such as cisplatin. Albei...

Descripción completa

Detalles Bibliográficos
Autores principales: Soma, Yu, Kawabe, Taiichi, Kitaji, Daiyu, Hoshino, Kaoru, Sunohara, Sumire, Iwano, Takehisa, Kawano, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052796/
https://www.ncbi.nlm.nih.gov/pubmed/36978021
http://dx.doi.org/10.1186/s12882-023-03116-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052796/
https://www.ncbi.nlm.nih.gov/pubmed/36978021
http://dx.doi.org/10.1186/s12882-023-03116-2

Ejemplares similares